Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1

Abstract Background Bladder cancer is a urological carcinoma with high incidence, among which muscle invasive bladder cancer (MIBC) is a malignant carcinoma with high mortality. There is an urgent need to develop new drugs with low toxicity and high efficiency for MIBC because existing medication ha...

詳細記述

書誌詳細

主要な著者:	Ruijiao Chen, Xiaopeng Hao, Jingyuan Chen, Changyue Zhang, Huixia Fan, Fuming Lian, Xiaochuan Chen, Chao Wang, Yong Xia
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-08-01
シリーズ:	Journal of Translational Medicine
主題:	Jorunnamycin A Muscle invasive bladder cancer Proteomics Transcriptomics Proliferation Apoptosis
オンライン･アクセス:	https://doi.org/10.1186/s12967-023-04400-3
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!